VNDANasdaqPharmaceutical PreparationsFiscal year ends December 31
Vanda Pharmaceuticals Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$4.09+0.06 (+1.49%)
Close on Oct 19, 2026
- Market cap
- $246.33M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Vanda Pharmaceuticals's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 6, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 5, 2026 | Aug 5, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 4, 2026 | Jun 5, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 7, 2026 | SEC EDGAR |
| Current report | 8-K | May 6, 2026 | May 6, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 4, 2026 | Apr 23, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 22, 2026 | Apr 22, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 29, 2026 | Apr 2, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 10, 2026 | Mar 10, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 20, 2026 | Feb 23, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 18, 2026 | Feb 19, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Feb 12, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 11, 2026 | Feb 11, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 7, 2026 | Jan 8, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 30, 2025 | Dec 31, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 4, 2025 | Dec 4, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 28, 2025 | Nov 28, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Oct 30, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 29, 2025 | Oct 29, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 1, 2025 | Oct 1, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Jul 31, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 31, 2025 | Jul 31, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 5, 2025 | Jun 5, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 8, 2025 | SEC EDGAR |
| Current report | 8-K | May 7, 2025 | May 7, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 5, 2025 | Apr 25, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 14, 2025 | Mar 17, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 18, 2025 | Feb 20, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Feb 14, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 13, 2025 | Feb 13, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 25, 2025 | Jan 27, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 7, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 6, 2024 | Nov 6, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 14, 2024 | Oct 15, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 2, 2024 | Oct 3, 2024 | SEC EDGAR |
| Current report | 8-K | Sep 19, 2024 | Sep 19, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 7, 2024 | Aug 8, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 1, 2024 | SEC EDGAR |
| Current report | 8-K | Jul 31, 2024 | Jul 31, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 19, 2024 | Jun 20, 2024 | SEC EDGAR |